Literature DB >> 20416989

[Frequency and risk factors of biological adrenal insufficiency screened by the 250 microg Synacthene stimulation test after a prolonged course of systemic glucocorticoid therapy. A study of 100 patients].

G Pugnet1, L Sailler, L Astudillo, J Vernet, A Bennet, P Arlet.   

Abstract

PURPOSE: The frequency of adrenal insufficiency after a prolonged, continuous course of oral high-dose corticosteroids is poorly documented. We evaluated it retrospectively in our internal medicine department.
METHODS: The patients were included between February 2000 and June 2007 and were administered a Synacthene 250 microg test (ST250) before tapering prednisone dose below 5mg per day. A non-responsive test was defined by a cortisol increase below 18 microg/dL, 60 min after stimulation. We also studied the risk factors associated with biological adrenal insufficiency by a multivariate logistic regression analysis.
RESULTS: Hundred patients were included (mean age: 61.5+/-16.3 years). Mean initial dose of corticosteroids was 65.5+/-112 mg/d. Forty-five patients failed to respond to the ST250. A normal ST250 was negatively associated with a duration of corticosteroids therapy longer than 19.5 months (OR=0.38 [0.15-0.94]; p=0.04) and positively with an age over 63.5 years (OR=2.5 [1.1-6.4]; p=0.05). Two patients experienced a clinical adrenal insufficiency crisis.
CONCLUSION: Biological adrenal insufficiency is very common after a prolonged course of oral high-dose corticosteroids. The risk does not seem to increase with age. The clinical benefit of a systematic ST250 at the time of corticosteroids withdrawal followed by hydrocortisone substitution if the test is non responsive remains unknown, and this practice is still a matter of debate. Copyright 2010 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416989     DOI: 10.1016/j.revmed.2009.12.006

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

1.  Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.

Authors:  Rebecca M Joseph; Ann Louise Hunter; David W Ray; William G Dixon
Journal:  Semin Arthritis Rheum       Date:  2016-03-09       Impact factor: 5.532

2.  Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study.

Authors:  Yvan Jamilloux; Eric Liozon; Gregory Pugnet; Sylvie Nadalon; Kim Heang Ly; Stephanie Dumonteil; Guillaume Gondran; Anne-Laure Fauchais; Elisabeth Vidal
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.